Dulac Edward J III 4
4 · FATE THERAPEUTICS INC · Filed Jan 30, 2024
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-29$5.00/sh−1,849$9,245→ 103,926 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.